Know Cancer

or
forgot password

Evaluation and Treatment of Subjects With Dermatologic Diseases


N/A
N/A
N/A
Open (Enrolling)
Both
Connective Tissue Disease, Skin Disease

Thank you

Trial Information

Evaluation and Treatment of Subjects With Dermatologic Diseases


Background

This is a training, natural history of disease, and screening protocol for the evaluation,
treatment and follow-up of patients with dermatologic diseases and systemic diseases with
cutaneous manifestations. This protocol was developed to allow subject enrollment for
teaching purposes and to allow for second opinions regarding relatively complicated
patients. The latter function promotes a critical link between the NCI, CCR Dermatology
Branch and the local and national extramural medical communities.

Objective

Primary:

- To provide clinical material to fulfill the educational mission of the

Dermatology Branch.

- To learn about the natural history of selected dermatologic diseases.

Secondary:

- To screen patients for inclusion in other protocols.

- To assist in the diagnosis and/or management of patients with rare skin diseases and
congenital or genetically linked skin conditions.

Eligibility

All subjects regardless of age, gender, or racial/ethnic group with dermatologic disease or
systemic disease with cutaneous manifestations.

Design

Patients enrolled in this protocol will be evaluated and treated according to generally
available, standard procedures and therapeutic modalities. Samples of blood and skin will be
studied by routine and specialized investigative methods to establish these patients'
diagnosis, response to treatment, and/or disease progression.

Inclusion Criteria


- INCLUSION CRITERIA:

Patients of any age, of both genders, and all racial/ethnic groups with dermatologic
diseases or systemic diseases with cutaneous manifestations.

Women of childbearing potential, or who are pregnant or lactating, will only undergo tests
and procedures, and/or receive medications for which data exists proving minimal risk to
the fetus and/or child. Only tests that are clinically indicated for diagnosis will be
performed.

Patients must be referred by a physician.

EXCLUSION CRITERIA:

Patients with cognitive impairment.

Pregnancy or lactation, if this status precludes proposed diagnostic procedures or
therapies because of known untoward effects on mother and/or child.

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

Mark C Udey, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)

Authority:

United States: Federal Government

Study ID:

960102

NCT ID:

NCT00001506

Start Date:

June 1996

Completion Date:

Related Keywords:

  • Connective Tissue Disease
  • Skin Disease
  • Training Protocol
  • Natural History
  • Consultation
  • Standard Therapy
  • Standard Tests
  • Training
  • Connective Tissue Diseases
  • Skin Diseases

Name

Location

National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, Maryland  20892